A comprehensive new review is shedding light on the growing evidence that gut microbiome imbalances—known as dysbiosis—may ...

MaaT Pharma Announces First Patient Randomized in IMMUNOLIFE Phase 2 Study Sponsored by Gustave Roussy, in Advanced NSCLC ...

If one were to ask a medical student 50 years ago, “What is the main function of the gastrointestinal tract?”, the answer would be simple: to help us digest, absorb and eliminate our food. Today’s ...

How microbial metabolites from everyday foods connect the gut, brain, and skin to influence inflammation, emotional health, ...

Chemotherapy commonly damages the intestinal lining, a well-known side effect. But this injury does not remain confined to ...

Please provide your email address to receive an email when new articles are posted on . Small intestinal bacterial overgrowth was present in 25% of patients with severe alcoholic hepatitis vs. 3.3% of ...

Chemotherapy reshapes gut bacteria in ways that send powerful signals throughout the body. These signals reprogram immune ...

Researchers showed chemotherapy injured the gut, altered microbes, and boosted indole-3-propionic acid, which reprogrammed ...

IMMUNOLIFE, a Phase 2 randomized exploratory study, will evaluate the potential of MaaT033 in combination with Cemiplimab versus Best Investigator Choice (i.e.: second line) in enhancing disease ...